Hepatitis C big problem for HIV patients

A new research conducted at the Perelman School of Medicine at the University of Pennsylvania stated that there is risk of hepatitis C is linked with the serious liver disease that is prevalent among the HIV patients it is differently beneficial from the antiretroviral therapy to treat HIV. The study is published in the Annals of Internal Medicine. The study shows that the HIV/hepatitis C-co-infected patients have increased to 80 percent higher rate of cirrhosis as compared to hepatitis C-only patients. The study's lead author, Vincent Lo Re III, MD, MSCE, assistant professor of Medicine and Epidemiology in the division of Infectious Diseases and department of Biostatistics and Epidemiology at Penn explained, “Our results suggest that serious consideration should be given to initiating hepatitis C treatment in patients co-infected with HIV and hepatitis C—particularly among those with advanced liver fibrosis or cirrhosis—in order to try to reduce the risk of serious, potentially life-threatening liver complications.”